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Background. Adhesion molecules, such as P-selectin, play
a pivotal role in leukocyte adhesion to the endothelium dur-
ing inflammation. We investigated the relationship between
P-selectin gene polymorphisms and albuminuria in 565 Euro-
pean American siblings (84% with type 2 diabetes) from 227
families participating in the Diabetes Heart Study (DHS).
Methods. Three common missense P-selectin polymorphisms
(S290N, N562D, and T715P) were genotyped. Albuminuria was
defined as an albumin:creatinine ratio (ACR) ≥ 17 mg/g in
males, and ≥ 25 mg/g in females. Tests of association were based
on generalized estimating equations (GEE1) and tests of link-
age disequilibrium were based on the quantitative pedigree dis-
equilibrium test (QPDT).
Results. Each copy of the 290Asn (S290N) allele was associ-
ated with a 45% absolute increase in ACR (P = 0.007), and a
higher risk for the presence of albuminuria [odds ratio (OR),
1.71 for each 290A sn allele] (P = 0.002). Adjustment for other
determinants of ACR, including stratification by age, gender,
and presence of diabetes, did not alter these results. Haploytpe
analyses using both GEE1 and QPDT methods revealed that
the N-N-T haplotype, containing asparagine codons at sites
S290N and N562D, was associated with an increased risk of
albuminuria (OR 1.77) (P = 0.005, for each additional copy of
the N-N-T haplotype).
Conclusion. The 290Asn (S290N) variant of P-selectin was
associated with a higher prevalence and greater degree of al-
buminuria in European American siblings of type 2 diabetic
families.
P-selectin is a 140 kD adhesion molecule that is ex-
pressed on the surface of activated platelets and vascu-
lar endothelial cells. This adhesion molecule mediates
leukocyte “rolling” on the endothelium in the earliest
stages of inflammation. [1] Soluble P-selectin, derived
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from platelets and endothelial cells, is positively asso-
ciated with an increased risk of cardiovascular disease
(CVD) events [2] and severity of renal impairment [3].
P-selectin mRNA expression has been detected in the en-
dothelium overlying atherosclerotic plaque but is absent
in normal arterial endothelium [4]. Adhesion molecules
are thought to be involved in diverse vascular disease
processes. As such, variation in the P-selectin gene may
account for a portion of the predisposition to endothelial
dysfunction and may regulate the physiologic response
to microalbuminuria.
The P-selectin gene is located on chromosome
1q21-q24. Among 14 identified P-selectin gene missense
polymorphisms, the proline (P) allele of the Thr715Pro
variant has been most intensively studied. Presence of the
Pro allele at this site has been shown to have a protective
effect on myocardial infarction in both the ECTIM and
the ECTIM extension studies [5, 6], but had no effect in
other studies [7, 8]. A recent haplotype-based association
study reported that the presence of two asparagine (N)
codons (at sites S290N and N562D) was associated with
an increased risk of myocardial infarction in French and
North Irish populations [9].
Microalbuminuria is a hallmark of endothelial dysfunc-
tion [10, 11]. We are not aware of other studies that have
examined the effect of P-selectin gene polymorphisms
on risk of albuminuria. In this report, we present the re-
sults of both genotype and haplotype family-based asso-
ciation analyses which were performed to investigate the
relationship between P-selectin polymorphisms and al-
buminuria in European American siblings from families
with multiple members with type 2 diabetes mellitus in
the Diabetes Heart Study (DHS).
METHODS
Study design and population
The DHS is conducted in Forsyth County, North
Carolina, to study the genetic epidemiology of
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cardiovascular and renal disease in families with multi-
ple individuals diagnosed with type 2 diabetes mellitus.
Siblings concordant for type 2 diabetes mellitus are re-
cruited in each family, along with one nondiabetic sibling,
where possible [12, 13]. Type 2 diabetes mellitus is de-
fined as diabetes developing after age 34 years and treated
with insulin and/or oral agents, in the absence of historic
evidence of ketoacidosis. Medication reviews were used
to corroborate the clinical diagnosis of type 2 diabetes
mellitus. Nondiabetic siblings had to have fasting blood
glucose (<126 mg/dL) to be classified as “nondiabetic.”
Diabetic cases reporting known chronic renal failure or
receiving renal replacement therapy were not recruited.
P-selectin was genotyped on 565 European American sib-
lings from 227 DHS families. There are 19 families with
one individual, 130 families with two individuals, 50 fam-
ilies with three individuals, 17 families with four individ-
uals, four families with five individuals, five families with
six individuals, and one family each with seven and nine
individuals. The study was approved by the Institutional
Review Board at the Wake Forest University School of
Medicine, and all participants gave informed consent.
Laboratory measurements
Subjects presented fasting to the General Clinical
Research Center at the Wake Forest University School
of Medicine for measurement of urinary albumin and
creatinine [for calculation of the albumin:creatinine ra-
tio (ACR)]; in addition, blood pressure and samples for
serum chemistries, hemoglobin A1c, fasting glucose, and
lipids were obtained.
Urine albumin was measured on a Model 1650 Advia
(Bayer Diagnostics, Tarrytown, NY, USA) using an au-
tomated immunoturbidity analysis. Urine creatinine was
measured using the picric acid reaction on the Advia. In
an alkaline medium, creatinine reacts with picric acid to
form a yellow-orange complex. Rate of color formation
is proportional to the concentration of creatinine present
and is measured photo-metrically at 505 nm. To maximize
agreement between serial specimens of the study popu-
lation, gender-specific cut points were chosen to delin-
eate normal from elevated albuminuria: ACR ≥17 mg/g
for males, and ACR ≥25 mg/g for females. These values
are approximately equivalent to albumin excretion rates
>30 lg/min in men and 31 lg/min in women [14].
Genomic DNA was extracted from peripheral lympho-
cytes. Based on DNA variations in the P-selectin gene
from the resequencing data of 24 African Americans and
23 Europeans [15], only three of 14 missense polymor-
phisms (S290N, N562D, and T715P) had allele frequen-
cies ≥5% in Europeans. These three polymorphisms were
genotyped using a MassARRAY single nucleotide poly-
morphism (SNP) genotyping system (Sequenom, Inc.,
San Diego, CA, USA).
Statistical analysis
Each polymorphism was tested for departure from
Hardy-Weinberg proportions using a chi-square good-
ness of fit test. The pair-wise linkage disequilibrium co-
efficients, D′ and r2, were calculated [16]. Albuminuria
(ACR) was analyzed as both a continuous and a di-
chotomous variable. The distributions of urine ACR were
highly skewed; thus, a natural logarithm transformation
was applied to ACR level in order to better approximate
the distributional assumptions of conditional normality
and homogeneity of variance. To account for familial
correlation, generalized estimating equations (GEE1),
assuming exchangeable correlations and using a robust
estimator of the variance, were calculated for all anal-
yses (SAS version 8.0) (SAS Institute Inc., Cary, NC,
USA). The multivariate GEE1 models adjusted for po-
tential non-genetic risk factors for ACR. Models were
developed for the overall sample and by strata of gender,
age (<60 vs. ≥60 years; mean age 62 years), and presence
of type 2 diabetes mellitus. The GEE1 analyses test for
association, and not linkage disequilibrium, between the
polymorphism and ACR. P values ≤ 0.05 were consid-
ered statistically significant.
Haplotypes were configured on the pedigree data (un-
der the assumption that there were no recombination
events between the polymorphisms) using the Zaplo pro-
gram [17]. Posterior probabilities of haplotypes for a sub-
ject, conditional on the observed marker data, were used
as weights in the GEE1 models. The Wald test was used
for testing global haplotype effect. An additive model was
used for testing the effect of haplotypes [e.g., E (Yi/H =
(h1, h2) = a + b 1 + b 2), where Y is a normal distributed
trait for i subject]. The reference haplotype was chosen
as the haploytpe combining the most frequent allele at
each polymorphic site.
To minimize the type 1 error rate, an approach similar
to Fisher’s protected least significant difference (LSD)
multiple comparisons procedure was used. First, the
genotype-based two degree-of-freedom general associa-
tion test was computed. If this test of general association
was significant, then the three a priori genetic models
(i.e., dominant, additive, and recessive) were tested with-
out further adjustment for multiple comparisons. If the
general test of association was not significant, then the
three a priori genetic models were tested after mak-
ing a sequential Bonferroni adjustment for the three
comparisons.
The quantitative pedigree disequilibrium test (QPDT)
[18] was performed to assess association of a specified al-
lele or haplotype with ACR. A likelihood ratio test was
performed, using the expectation-maximization (EM) al-
gorithm to account for haplotype ambiguities. The QPDT
analysis was further conducted with residuals adjusted for
potential nongenetic risk factors for ACR, including age,
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Table 1. Characteristics of 565 European American Diabetes Heart Study participants, by albuminuria status
Albuminuriaa
Yes No
Characteristic N = 192 N = 373 P valueb
Demographic
Mean age (SD) years 62.8 (9.6) 61.3 (9.5) 0.09
% female 45.8 61.1 0.0005
Smoking
% former smoker 35.4 43.1
% current smoker 23.9 16.8 0.07
Clinical
% Diabetes 93 79 <0.0001
Median duration of diabetes (interquartile range) years 9 (5, 15) 6 (2, 12) 0.0005
% Self-reported cardiovascular disease 42 29 0.002
Mean systolic blood pressure (SD) mm Hg 145 (20) 137(18) <0.0001
Mean diastolic blood pressure (SD) mm Hg 74 (11) 74 (10) 0.80
% Lipid-lowering medication 43 34 0.04
% Angiotensin-converting enzyme inhibitors 58 45 0.003
% Angiotensin-converting enzyme inhibitors or angiotension II 58 45 0.003
receptor blockers
Laboratory
Mean cholesterol (SD) mg/dLc 190 (45) 189 (41) 0.82
Mean hemoglobin A1c (SD) 8.1% (1.9%) 7.2% (1.9%) <0.0001
Mean serum creatinine (SD) mg/dL 1.17 (0.38) 1.03 (0.28) <0.0001
Median albumin:creatinine ratio (interquartile range) 6.50 58.62 <0.0001
(3.94, 10.65) (30.30, 149.21)
S290N (Ser → Asn) %
Ser/Ser 63.0 75.1
Ser/Asn 33.3 24.1
Asn/Asn 3.7 0.8 0.002
N562D (Asn → Asp) %
Asn/Asn 34.3 31.2
Asn/Asp 47.0 47.9
Asp/Asp 18.8 20.9 0.73
T715P (Thr → Pro) %
Thr/Thr 76.0 75.5
Thr/Pro 22.9 23.3
Pro/Pro 1.1 1.2 0.99
aAlbuminuria defined as albumin:creatinine ratio ≥17 mg/g in men, ≥25 mg/g in women; bby chi-square, t test, or Mann-Whitney U test; cto convert values for
cholesterol to millimoles per liter, multiply by 0.02586.
gender, smoking, and presence of type 2 diabetes mellitus.
Unlike the population-based GEE approach, the family-
based QPDT analysis tends to be modestly conservative
in the presence of population stratification and is a valid
test of linkage disequilibrium even in the presence of as-
certainment (selection) bias.
RESULTS
Cross-sectional study
Eighty-four percent (472/565) of all participants had
type 2 diabetes mellitus and 34% (192/565) had an ele-
vated ACR. Table 1 contains the clinical characteristics
of the 565 family members by level of albuminuria. Par-
ticipants with albuminuria tended to be older, diabetic,
male, and current smokers. They also more frequently
presented with preexisting CVD, taking lipid- and blood
pressure-lowering medications, having longer diabetes
duration, and higher systolic blood pressure, hemoglobin
A1c, and serum creatinine concentrations.
In the 230 unrelated probands, the genotype frequen-
cies of the S290N [Asn (N) allele frequency = 0.14],
the N562D [Asp (D) allele frequency = 0.47], and the
T715P [Pro (P) allele frequency = 0.13] polymorphisms
were consistent with Hardy-Weinberg expectations.
Table 1 demonstrates that the genotype distribution sig-
nificantly differed between the high and low ACR groups
for the S290N polymorphism, but not for the N562D or
T715P polymorphisms. The genotypes, 290Ser/Asn and
290Asn/Asn, were more frequently present in the sub-
group with higher ACR.
The median ACR [interquartile range (IQR)] was
10.00 (4.76, 27.44) for 290Ser homozygotes, 13.27 (5.56,
43.48) for 290Ser/Asn heterozygotes, and 25.57 (15.79,
189.13) for 290Asn homozygotes. Univariate GEE1 anal-
ysis revealed that the 290Asn (N) allele was associated
with increased ACR (an increase of 45% in ACR for
each additional copy of the N allele) (P= 0.007) and a
higher risk for the presence of albuminuria [odds ratio
(OR) 1.71 for each additional copy of the N allele] (P=
0.002). These associations remained highly significant
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Table 2. Adjusteda association of 290Asn allele with presence of albuminuria and urine albumin:creatinine ratio (ACR)
Albuminuriab ln ACRc
Pinteraction
OR for differences in eß
Number (95% CI) P value subgroup ORs (95% CI) P value
Overall 565 1.86 (1.28, 2.70) 0.001 1.43 (1.11, 1.85) 0.006
Gender
Female 316 1.95 (1.20, 3.17) 0.007 1.54 (1.09, 2.16) 0.01
Male 249 1.79 (1.00, 3.21) 0.05 0.91 1.39 (0.93, 2.08) 0.11
Age
<60 years 241 2.23 (1.28, 3.89) 0.005 1.54 (1.09, 2.16) 0.01
≥60 years 324 1.66 (1.04, 2.66) 0.03 0.93 1.31 (0.95, 1.80) 0.10
Diabetes
Yes 472 1.62 (1.08, 2.43) 0.02 1.38 (1.02, 1.86) 0.03
No 93 6.24 (2.28, 17.09) 0.004 0.05 2.44 (1.26, 4.71) 0.008
aAdjusted for age, gender, smoking, and type 2 diabetes mellitus in an additive generalized estimated equation (GEE1) model; bAlbuminuria defined as ACR ≥17
mg/g in men, ≥25 mg/g in women.
after adjustment for age, gender, smoking, and history of
type 2 diabetes mellitus in an additive association model
(ratio of geometric mean of ACR 1.43) (P= 0.006) (OR
of albuminuria 1.86) (P= 0.001) for each additional copy
of the N allele in the overall group (Table 2). Further ad-
justment for diabetes duration, hemoglobin A1c, systolic
and diastolic blood pressure, cholesterol concentration,
prevalent CVD, and use of angiotensin-converting en-
zyme (ACE) inhibitors, angiotension II receptor block-
ers, and lipid-lowering medications did not substantially
alter the results (data not shown). The observed differ-
ences were consistent in subgroups, stratified by gender,
age (<60 vs. ≥60 years), and presence of type 2 diabetes
mellitus (Table 2).
The N562D and T715P polymorphisms are in linkage
dysequilibrium (D′ = 1.0; r2 = 0.13); however, neither is
strongly linked to the S290N polymorphism (D′ = 0.10
with N562D; D′ = 0.26 with T715P). Six haplotypes, S-N-
T (40%), S-D-T (38%), S-N-P (7%), N-N-T (8%), N-D-
T (5%), and N-N-P (1%), were inferred using the three
polymorphisms (Fig. 1). The test of a global haplotype
association with ACR was statistically significant (P=
0.018). Using the S-N-T haplotype as a reference (com-
bining the most frequent alleles at each polymorphic site),
the N-N-T haplotype was associated with a higher risk of
albuminuria (OR 1.77; 95% CI 1.19–2.63) (P= 0.005 for
each additional copy of the N-N-T haplotype). Significant
associations were not observed for the remaining haplo-
types, although the two haplotypes containing the 290N
allele, N-D-T and N-N-P, had a trend toward association
with increasing albuminuria (Fig. 1).
Family-based study
The findings of the population-based GEE1 analysis
were examined using a family-based method (QPDT)
to test for linear dysequilibrium between the P-selectin
polymorphisms and ACR. Table 3 presents results that
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Fig. 1. Adjusted odds ratio (OR) and its 95% CI for albuminuria asso-
ciated with P-selectin haplotypes in an additive model, compared to the
most common haploytpe, S-N-T. ∗∗P = 0.005 adjusted for age, gender,
smoking, type 2 diabetes mellitus in a generalized estimated equation
(GEE1) model. d.f., degree of freedom.
suggest transmission of the 290N allele contributes to in-
creased ACR (P= 0.049). Transmission of the six hap-
lotypes defined by the three polymorphisms was also
examined (Table 3). The N-N-T haplotype was transmit-
ted significantly more often to offspring with higher ACR.
These transmission distortions remained significant (P=
0.005) after further adjustment for age, gender, smoking,
and history of type 2 diabetes mellitus.
DISCUSSION
Herein, we report evidence of an association between
genetic variation in the P-selectin gene and albuminuria
in a population of European American families enriched
for the presence of type 2 diabetes mellitus. Geno-
type analyses revealed that the coding changes at codon
290 were specifically associated with an excess risk of
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Table 3. Quantitative pedigree disequilibrium test (QPDT) analysis
of the P-selectin alleles and haplotypes with urine albumin:creatinine
ratio (ACR)
Minor allele Multivariatea
Single nucleotide polymorphism or haplotype
SNP/haplotype frequency Z score P value
SNP
S290N (Ser → Asn) 0.15 1.97 0.049
N562D (Asn → Asp) 0.44 −0.023 0.98
T715P (Thr → Pro) 0.13 0.29 0.77
3-SNP Haplotype
S-N-T 0.40 −0.35 0.73
S-D-T 0.38 −0.84 0.40
S-N-P 0.07 −0.42 0.67
N-N-T 0.08 2.83 0.005
N-D-T 0.05 −0.49 0.62
N-N-P 0.012 0.12 0.89
aAdjusted for age, gender, smoking, and history of type 2 diabetes mellitus.
albuminuria. This association was present in both diabetic
and nondiabetic individuals, suggesting that P-selectin
polymorphisms play an important role in endothelial dys-
function manifested by albuminuria, independent of dia-
betes status.
The association between the S290N polymorphism and
albuminuria was also identified through haplotype anal-
yses. The N-N-T haplotype appeared to contribute most
strongly to this association. To date, no other report has
examined the association of P-selectin polymorphisms
with either nephropathy or proteinuria. A recent Euro-
pean study illustrated the combined effect of the presence
of asparagine (N) at sites S290N and N562D on predis-
position to myocardial infarction in French and North
Irish populations [9]. This study concluded that a min-
imum of the three polymorphisms, S290N, N562D, and
T715P, should be genotyped in any study that investi-
gates P-selectin in disease etiology. The haplotype struc-
ture and frequency reported in Europeans was similar to
that observed in the DHS, and the specific haplotype ef-
fect that was observed is consistent with our results. In
the DHS, there was no association of the T715P poly-
morphism with albuminuria, although equivocal results
have also been reported for the association of T715P
with coronary artery disease [5–9]. Only one haplotype
(S-N-P) carrying the 715P allele was identified in the
European study [9], and was more frequent in the North
Irish (0.134) than in the French (0.08). This haplotype
was similarly infrequent in our European American DHS
population (0.07).
Multiple lines of evidence support an important role
for leukocyte adhesion molecules in the pathogenesis
of glomerular inflammation. The mechanisms potentially
responsible for the association of the specific haplotype
with albuminuria can be postulated based upon the lo-
cation of the S290N and N562D polymorphisms in the
P-selectin gene. These polymorphic sites are located
within the consensus repeat domain of the P-selectin pro-
tein, a region important for the binding of P-selectin to its
ligand on leukoctyes [9, 19, 20]. Therefore, Tregouet et al
[9] hypothesized that the variation at these sites can result
in a protein that is more efficient at recruiting leukoctyes
to the endothelium.
Our current study has several limitations that should
be acknowledged. Urine ACR was measured in duplicate
on only a single occasion. Variation in ACR is known
to occur when frequent measurements are performed
[21]. However, unmeasured within-individual variation
would be expected to reduce the magnitude of the as-
sociation. Although these analyses are based exclusively
on self-reported European Americans, it is possible that
there exists within ethnicity population structure. The
consistency of the family-based QPDT results with the
GEE1-based association results suggests that any po-
tential population substructure within our sample is not
influencing our results. Due to our relatively small sam-
ple size and the rare frequency of the other two haplo-
types containing the 290Asn allele, N-D-T and N-N-P, we
were unable to determine whether their null associations
with albuminuria were due to limited power. Further, this
study was limited to European Americans, so the ability
to generalize these findings to other ethnic groups is un-
certain. The association between the 290Asn allele and
estimated glomerular filtration rate (GFR), however, was
only marginally significant (data not shown). This sug-
gests that ACR and GFR represent different pathophys-
iologic processes.
CONCLUSION
The S290N P-selectin polymorphism independently
predicts urinary ACR and a higher risk of albuminuria
in members of European American families enriched
for the presence of type 2 diabetes. This finding could
be due to the simultaneous presence of the 290Asn and
562Asn that could alter the function of the P-selectin pro-
tein, thereby resulted in endothelial dysfunction and, ul-
timately, increased risk for albuminuria. Albuminuria is a
hallmark of both progressive renal disease and endothe-
lial dysfunction. Confirmation of the independent effect
of the P-selectin gene polymorphisms on susceptibility to
albuminuria in other cohorts will strengthen our under-
standing of the links between albuminuria, nephropathy,
and CVD. Future studies are needed to provide func-
tional data directly supporting the S290N variant’s contri-
bution to albuminuria. Specific P-selectin haplotypes may
help to identify individuals at high risk for subsequent al-
buminuria and CVD and allow for earlier institution of
preventive measures. P-selectin may also serve as a novel
pharmacologic target, whose disruption could block in-
flammation leading to endothelial dysfunction and pro-
gressive renal disease.
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